Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ying Mu, Michelle Pham, Anthony T. Podany & Theodore J. Cory. (2020) Evaluating emtricitabine + rilpivirine + tenofovir alafenamide in combination for the treatment of HIV-infection. Expert Opinion on Pharmacotherapy 21:4, pages 389-397.
Read now
Read now
Deqing Xiao, Kah Hiing John Ling, Joseph Custodio, Sophia R. Majeed & Thomas Tarnowski. (2018) Quantitation of intracellular triphosphate metabolites of antiretroviral agents in peripheral blood mononuclear cells (PBMCs) and corresponding cell count determinations: review of current methods and challenges. Expert Opinion on Drug Metabolism & Toxicology 14:8, pages 781-802.
Read now
Read now
Katya C. Corado & Eric S. Daar. (2017) Emtricitabine + tenofovir alafenamide for the treatment of HIV. Expert Opinion on Pharmacotherapy 18:4, pages 427-432.
Read now
Read now
Nicolas A. Margot, Kathryn M. Kitrinos, Marshall Fordyce, Scott McCallister, Michael D. Miller & Christian Callebaut. (2016) Rare emergence of drug resistance in HIV-1 treatment -naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide. HIV Clinical Trials 17:2, pages 78-87.
Read now
Read now
Stefano Bonora, Andrea Calcagno, Alice Trentalange & Giovanni Di Perri. (2016) Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults. Expert Opinion on Pharmacotherapy 17:3, pages 409-419.
Read now
Read now
Articles from other publishers (71)
Huijuan Li, Minyan Yang, Mina Ma, Zijun Li, Meixuan Li, LongDong Zhu, Liang Yao, Junfeng Li, Linda Zhong & Kehu Yang. (2023) Tenofovir for children and adults with chronic hepatitis B. Cochrane Database of Systematic Reviews 2023:9.
Crossref
Crossref
Shin-Tian Chien, Ian T. Suydam & Kim A. Woodrow. (2023) Prodrug approaches for the development of a long-acting drug delivery systems. Advanced Drug Delivery Reviews 198, pages 114860.
Crossref
Crossref
Elaine E. To. (2023) Cell and Tissue Specific Metabolism of Nucleoside and Nucleotide Drugs: Case Studies and Implications for Precision Medicine. Drug Metabolism and Disposition 51:3, pages 360-368.
Crossref
Crossref
Junbiao Chang & Wenquan Yu. 2023. Nucleic Acids in Medicinal Chemistry and Chemical Biology. Nucleic Acids in Medicinal Chemistry and Chemical Biology
1
40
.
Victoria C. Yan, Cong-Dat Pham, Elliot S. Ballato, Kristine L. Yang, Kenisha Arthur, Sunada Khadka, Yasaman Barekatain, Prakriti Shrestha, Theresa Tran, Anton H. Poral, Mykia Washington, Sudhir Raghavan, Barbara Czako, Federica Pisaneschi, Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi, Jeffrey J. Ackroyd, Dimitra K. Georgiou, Steven W. Millward & Florian L. Muller. (2022)
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of
ENO1
-Deleted Cancers
. Journal of Medicinal Chemistry 65:20, pages 13813-13832.
Crossref
Crossref
Aaminat Qureshi, Louise A. Ouattara, Naglaa Salem El-Sayed, Amita Verma, Gustavo F. Doncel, Muhammad Iqbal Choudhary, Hina Siddiqui & Keykavous Parang. (2022) Synthesis and Evaluation of Anti-HIV Activity of Mono- and Di-Substituted Phosphonamidate Conjugates of Tenofovir. Molecules 27:14, pages 4447.
Crossref
Crossref
Erik De Clercq. (2021) Tribute to John C. Martin at the Twentieth Anniversary of the Breakthrough of Tenofovir in the Treatment of HIV Infections. Viruses 13:12, pages 2410.
Crossref
Crossref
Kellan T. Passow, Haley S. Caldwell, Kiet A. Ngo, Jamie J. Arnold, Nicole M. Antczak, Anoop Narayanan, Joyce Jose, Shana J. Sturla, Craig E. Cameron, Alexander T. Ciota & Daniel A. Harki. (2021) A Chemical Strategy for Intracellular Arming of an Endogenous Broad-Spectrum Antiviral Nucleotide. Journal of Medicinal Chemistry 64:20, pages 15429-15439.
Crossref
Crossref
Kuan-Ju Chen, Adam J. Plaunt, Franziska G. Leifer, Jeong Yeon Kang & David Cipolla. (2021) Recent advances in prodrug-based nanoparticle therapeutics. European Journal of Pharmaceutics and Biopharmaceutics 165, pages 219-243.
Crossref
Crossref
Markéta Pimková Polidarová, Petra Břehová, Martin Maxmilian Kaiser, Miroslav Smola, Martin Dračínský, Joshua Smith, Aleš Marek, Milan Dejmek, Michal Šála, Ondrej Gutten, Lubomír Rulíšek, Barbora Novotná, Andrea Brázdová, Zlatko Janeba, Radim Nencka, Evzen Boura, Ondřej Páv & Gabriel Birkuš. (2021) Synthesis and Biological Evaluation of Phosphoester and Phosphorothioate Prodrugs of STING Agonist 3′,3′-c-Di(2′F,2′dAMP). Journal of Medicinal Chemistry 64:11, pages 7596-7616.
Crossref
Crossref
Amedeo De Nicolò, Alessandra Manca, Alice Ianniello, Alice Palermiti, Andrea Calcagno, Micol Ferrara, Miriam Antonucci, Jessica Cusato, Valeria Avataneo, Elisa De Vivo, Stefano Bonora, Francesco Giuseppe De Rosa, Giovanni Di Perri & Antonio D’Avolio. (2021) Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma. Pharmaceuticals 14:5, pages 460.
Crossref
Crossref
Donald J. AbrahamPaul W. Erhardt, Rahul Khupse, Jeffrey G. Sarver & Brian J. Kress. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
105
.
Guangdi Li, Ming Xu, Tingting Yue, Weijie Gu & Li Tan. (2021) Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq. Biochemical Pharmacology 185, pages 114485.
Crossref
Crossref
Maria E. Cilento, Karen A. Kirby, Philip R. Tedbury & Stefan G. Sarafianos. 2021. Encyclopedia of Biological Chemistry III. Encyclopedia of Biological Chemistry III
92
104
.
Victoria C. Yan, Cong-Dat Pham, Kenisha Arthur, Kristine L. Yang & Florian L. Muller. (2020) Aliphatic amines are viable pro-drug moieties in phosphonoamidate drugs. Bioorganic & Medicinal Chemistry Letters 30:24, pages 127656.
Crossref
Crossref
Andrew J. Wiemer. (2020) Metabolic Efficacy of Phosphate Prodrugs and the Remdesivir Paradigm. ACS Pharmacology & Translational Science 3:4, pages 613-626.
Crossref
Crossref
Ivana Massud, Susan Ruone, Maria Zlotorzynska, Richard Haaland, Patrick Mills, Mian-er Cong, Kristen Kelley, Ryan Johnson, Angela Holder, Chuong Dinh, George Khalil, Yi Pan, Colleen F. Kelley, Travis Sanchez, Walid Heneine & J. Gerardo García-Lerma. (2020) Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques. EBioMedicine 58, pages 102894.
Crossref
Crossref
Deqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, Sophia R. Majeed, Brian Kearney, Christos Kolaris & Susan Zondlo. (2019) The determination of human peripheral blood mononuclear cell counts using a genomic DNA standard and application in tenofovir diphosphate quantitation. Analytical Biochemistry 585, pages 113399.
Crossref
Crossref
Ivana Massud, Mian-Er Cong, Susan Ruone, Angela Holder, Chuong Dinh, Kenji Nishiura, George Khalil, Yi Pan, Jonathan Lipscomb, Ryan Johnson, Frank Deyounks, James F Rooney, Darius Babusis, Yeojin Park, Scott McCallister, Christian Callebaut, Walid Heneine & J Gerardo García-Lerma. (2019) Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques. The Journal of Infectious Diseases 220:11, pages 1826-1833.
Crossref
Crossref
Kenji Maeda, Debananda Das, Takuya Kobayakawa, Hirokazu Tamamura & Hiroaki Takeuchi. (2019) Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication. Current Topics in Medicinal Chemistry 19:18, pages 1621-1649.
Crossref
Crossref
Thuy Hoang, Abhijit A. Date, Jairo Ortiz Ortiz, Ting-Wei Young, Sabrine Bensouda, Peng Xiao, Mark Marzinke, Lisa Rohan, Edward J. Fuchs, Craig Hendrix, Sanjeev Gumber, Francois Villinger, Richard A. Cone, Justin Hanes & Laura M. Ensign. (2019) Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema. European Journal of Pharmaceutics and Biopharmaceutics 138, pages 23-29.
Crossref
Crossref
Saeed Mohammadi, Shiva Akbari-Birgani, Meysam Borji, Babak Kaboudin & Mohammad Vaezi. (2019) Diethyl [(3-phenoxy-2-oxo-4-phenyl-azetidin-1-yl)-phenyl-methyl]-phosphonate as a potent anticancer agent in chemo-differentiation therapy of acute promyelocytic leukemia. European Journal of Pharmacology 846, pages 79-85.
Crossref
Crossref
Nicholas A. Lentini, Benjamin J. Foust, Chia-Hung Christine Hsiao, Andrew J. Wiemer & David F. Wiemer. (2018) Phosphonamidate Prodrugs of a Butyrophilin Ligand Display Plasma Stability and Potent Vγ9 Vδ2 T Cell Stimulation. Journal of Medicinal Chemistry 61:19, pages 8658-8669.
Crossref
Crossref
Hangzhou Shen, Yingshuai Liu, Xiaomeng Tian, Xiquan Zhang & Yinsheng Zhang. (2018)
An Efficient Pd & Pt‐Catalyzed H/D Exchange Approach towards the Synthesis of Deuterium‐Labeled Antiviral Prodrugs, Tenofovir Disoproxil Fumarate and
Tenofovir Alafenamide
. ChemistrySelect 3:30, pages 8724-8728.
Crossref
Crossref
Jarkko Rautio, Nicholas A. Meanwell, Li Di & Michael J. Hageman. (2018) The expanding role of prodrugs in contemporary drug design and development. Nature Reviews Drug Discovery 17:8, pages 559-587.
Crossref
Crossref
Erik De Clercq. (2018) Role of tenofovir alafenamide (TAF) in the treatment and prophylaxis of HIV and HBV infections. Biochemical Pharmacology 153, pages 2-11.
Crossref
Crossref
Youcef Mehellou, Hardeep S. RattanJan Balzarini. (2017) The ProTide Prodrug Technology: From the Concept to the Clinic. Journal of Medicinal Chemistry 61:6, pages 2211-2226.
Crossref
Crossref
Martin S. Davey, Roshni Malde, Rory C. Mykura, Alfie T. Baker, Taher E. Taher, Cécile S. Le Duff, Benjamin E. Willcox & Youcef Mehellou. (2018)
Synthesis and Biological Evaluation of (
E
)-4-Hydroxy-3-methylbut-2-enyl Phosphate (HMBP) Aryloxy Triester Phosphoramidate Prodrugs as Activators of Vγ9/Vδ2 T-Cell Immune Responses
. Journal of Medicinal Chemistry 61:5, pages 2111-2117.
Crossref
Crossref
Maxime Bessières, Vincent Hervin, Vincent Roy, Agnès Chartier, Robert Snoeck, Graciela Andrei, Jean-François Lohier & Luigi A. Agrofoglio. (2018) Highly convergent synthesis and antiviral activity of (E)-but-2-enyl nucleoside phosphonoamidates. European Journal of Medicinal Chemistry 146, pages 678-686.
Crossref
Crossref
Jarkko Rautio, Jussi Kärkkäinen & Kenneth B. Sloan. (2017) Prodrugs – Recent approvals and a glimpse of the pipeline. European Journal of Pharmaceutical Sciences 109, pages 146-161.
Crossref
Crossref
Dzintars Gotham, Andrew Hill & Anton L. Pozniak. (2017) Candidates for inclusion in a universal antiretroviral regimen. Current Opinion in HIV and AIDS 12:4, pages 324-333.
Crossref
Crossref
Bryon Simmons, Zhuqing Liu, Artis Klapars, Ana Bellomo & Steven M. Silverman. (2017) Mechanism-Based Solution to the ProTide Synthesis Problem: Selective Access to Sofosbuvir, Acelarin, and INX-08189. Organic Letters 19:9, pages 2218-2221.
Crossref
Crossref
Melynda E. Watkins, Steve Wring, Ryan Randolph, Seonghee Park, Kendall Powell, Lissa Lutz, Michelle Nowakowski, Ram Ramabhadran & Paul L. Domanico. (2017) Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate. Journal of Pharmaceutical Sciences 106:3, pages 906-919.
Crossref
Crossref
Jamie M. McCabe Dunn, Mikhail Reibarkh, Edward C. Sherer, Robert K. Orr, Rebecca T. Ruck, Bryon Simmons & Ana Bellomo. (2017) The protecting-group free selective 3′-functionalization of nucleosides. Chemical Science 8:4, pages 2804-2810.
Crossref
Crossref
S.E. Lazerwith, D. Siegel, R.M. McFadden, M.R. Mish & W.C. Tse. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
628
664
.
Peter J. ThorntonHachemi KadriAgeo MiccoliYoucef Mehellou. (2016) Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates. Journal of Medicinal Chemistry 59:23, pages 10400-10410.
Crossref
Crossref
Vijaya Madhyanapu Golla, Moolchand Kurmi, Karimullah Shaik & Saranjit Singh. (2016) Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its degradation and stability behaviour with tenofovir disoproxil fumarate. Journal of Pharmaceutical and Biomedical Analysis 131, pages 146-155.
Crossref
Crossref
Erik De Clercq. (2016) Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF). Biochemical Pharmacology 119, pages 1-7.
Crossref
Crossref
Ivana Massud, James Mitchell, Darius Babusis, Frank Deyounks, Adrian S. Ray, James F. Rooney, Walid Heneine, Michael D. Miller & J. Gerardo García-Lerma. (2016) Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus Infection. Journal of Infectious Diseases 214:7, pages 1058-1062.
Crossref
Crossref
Youcef Mehellou. (2016) The ProTides Boom. ChemMedChem 11:11, pages 1114-1116.
Crossref
Crossref
Ji Hwan Bang. (2016) Recent Advances of Antiretroviral Agents. The Korean Journal of Medicine 90:6, pages 481-486.
Crossref
Crossref
Rochelle P. Walensky, Tim H. Horn & A. David Paltiel. (2016) The Epi-TAF for Tenofovir Disoproxil Fumarate?: Table 1.. Clinical Infectious Diseases 62:7, pages 915-918.
Crossref
Crossref
Gabriel Birkus, Rujuta A. Bam, Madeleine Willkom, Christian R. Frey, Luong Tsai, Kirsten M. Stray, Stephen R. Yant & Tomas Cihlar. (2016) Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors. Antimicrobial Agents and Chemotherapy 60:1, pages 316-322.
Crossref
Crossref
Adrian S. Ray, Marshall W. Fordyce & Michael J.M. Hitchcock. (2016) Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus. Antiviral Research 125, pages 63-70.
Crossref
Crossref
Andrew J. Wiemer, Rebekah R. Shippy, Ashley M. Kilcollins, Jin Li, Chia-Hung Christine Hsiao, Rocky J. Barney, M. Lei Geng & David F. Wiemer. (2016) Evaluation of a 7-Methoxycoumarin-3-carboxylic Acid Ester Derivative as a Fluorescent, Cell-Cleavable, Phosphonate Protecting Group. ChemBioChem 17:1, pages 52-55.
Crossref
Crossref
Erik De Clercq. (2015) An Odyssey in antiviral drug development—50 years at the Rega Institute: 1964–2014. Acta Pharmaceutica Sinica B 5:6, pages 520-543.
Crossref
Crossref
Vedanjali Gogineni, Raymond F. Schinazi & Mark T. Hamann. (2015) Role of Marine Natural Products in the Genesis of Antiviral Agents. Chemical Reviews 115:18, pages 9655-9706.
Crossref
Crossref
Rujuta A Bam, Gabriel Birkus, Darius Babusis, Tomas Cihlar & Stephen R Yant. (2013)
Metabolism and Antiretroviral Activity of Tenofovir Alafenamide in CD4
+
T-Cells and Macrophages from Demographically Diverse Donors
. Antiviral Therapy 19:7, pages 669-677.
Crossref
Crossref
Ugo Pradere, Ethel C. Garnier-Amblard, Steven J. Coats, Franck Amblard & Raymond F. Schinazi. (2014) Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs. Chemical Reviews 114:18, pages 9154-9218.
Crossref
Crossref
Andrew J. Wiemer & David F. Wiemer. 2015. Phosphorus Chemistry I. Phosphorus Chemistry I
115
160
.
Erik De Clercq. (2013) A Cutting‐Edge View on the Current State of Antiviral Drug Development. Medicinal Research Reviews 33:6, pages 1249-1277.
Crossref
Crossref
Erik De Clercq. (2013) Dancing with chemical formulae of antivirals: A personal account. Biochemical Pharmacology 86:6, pages 711-725.
Crossref
Crossref
Michael J. Sofia. 2013. Successful Strategies for the Discovery of Antiviral Drugs. Successful Strategies for the Discovery of Antiviral Drugs
421
450
.
Randall Tressler & Catherine Godfrey. (2012) NRTI Backbone in HIV Treatment. Drugs 72:16, pages 2051-2062.
Crossref
Crossref
J. Gerardo García-Lerma & Walid Heneine. (2012) Animal models of antiretroviral prophylaxis for HIV prevention. Current Opinion in HIV and AIDS 7:6, pages 505-513.
Crossref
Crossref
Adrian S. Ray & Karl Y. Hostetler. (2011) Application of kinase bypass strategies to nucleoside antivirals. Antiviral Research 92:2, pages 277-291.
Crossref
Crossref
J. Gerardo García-Lerma, Wutyi Aung, Mian-er Cong, Qi Zheng, Ae S. Youngpairoj, James Mitchell, Angela Holder, Amy Martin, Susan Kuklenyik, Wei Luo, Carol Yen-Chin Lin, Debra L. Hanson, Ellen Kersh, Chou-Pong Pau, Adrian S. Ray, James F. Rooney, William A. Lee & Walid Heneine. (2011) Natural Substrate Concentrations Can Modulate the Prophylactic Efficacy of Nucleotide HIV Reverse Transcriptase Inhibitors. Journal of Virology 85:13, pages 6610-6617.
Crossref
Crossref
Youcef Mehellou, Jan Balzarini & Christopher McGuigan. (2009) Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells. ChemMedChem 4:11, pages 1779-1791.
Crossref
Crossref
Tomas Cihlar, William E. DelaneyIVIV & Richard Mackman. 2008. Modified Nucleosides. Modified Nucleosides
601
630
.
Gabriel Birkus, Nilima Kutty, Gong-Xin He, Andrew Mulato, William Lee, Martin McDermott & Tomas Cihlar. (2008)
Activation of 9-[(
R
)-2-[[(
S
)-[[(
S
)-1-(Isopropoxycarbonyl)ethyl]amino] phenoxyphosphinyl]-methoxy]propyl]adenine (GS-7340) and Other Tenofovir Phosphonoamidate Prodrugs by Human Proteases
. Molecular Pharmacology 74:1, pages 92-100.
Crossref
Crossref
Jarkko Rautio, Hanna Kumpulainen, Tycho Heimbach, Reza Oliyai, Dooman Oh, Tomi Järvinen & Jouko Savolainen. (2008) Prodrugs: design and clinical applications. Nature Reviews Drug Discovery 7:3, pages 255-270.
Crossref
Crossref
Sung-Up Choi, Tot Bui & Rodney J.Y. Ho. (2008) pH-Dependent Interactions of Indinavir and Lipids in Nanoparticles and Their Ability to Entrap a Solute. Journal of Pharmaceutical Sciences 97:2, pages 931-943.
Crossref
Crossref
Gabriel Birkus, Ruth Wang, Xiaohong Liu, Nilima Kutty, Holly MacArthur, Tomas Cihlar, Craig Gibbs, Swami Swaminathan, William Lee & Martin McDermott. (2007) Cathepsin A Is the Major Hydrolase Catalyzing the Intracellular Hydrolysis of the Antiretroviral Nucleotide Phosphonoamidate Prodrugs GS-7340 and GS-9131. Antimicrobial Agents and Chemotherapy 51:2, pages 543-550.
Crossref
Crossref
Tomoki Imaoka, Hiroyuki Kusuhara, Masashi Adachi, John D. Schuetz, Kenji Takeuchi & Yuichi Sugiyama. (2007) Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir. Molecular Pharmacology 71:2, pages 619-627.
Crossref
Crossref
Gong-Xin He, Jeffrey P. Krise & Reza Oliyai. 2007. Prodrugs. Prodrugs
923
964
.
Tomas Cihlar, Gong-Xin He, Xiaohong Liu, James M. Chen, Marcos Hatada, Swami Swaminathan, Martin J. McDermott, Zheng-Yu Yang, Andrew S. Mulato, Xiaowu Chen, Stephanie A. Leavitt, Kirsten M. Stray & William A. Lee. (2006) Suppression of HIV-1 Protease Inhibitor Resistance by Phosphonate-mediated Solvent Anchoring. Journal of Molecular Biology 363:3, pages 635-647.
Crossref
Crossref
Tomas Cihlar. (2006) Nucleotide HIV reverse transcriptase inhibitors: tenofovir and beyond. Current Opinion in HIV and AIDS 1:5, pages 373-379.
Crossref
Crossref
William A. Lee, Gong-Xin He, Eugene Eisenberg, Tomas Cihlar, Swami Swaminathan, Andrew Mulato & Kenneth C. Cundy. (2005) Selective Intracellular Activation of a Novel Prodrug of the Human Immunodeficiency Virus Reverse Transcriptase Inhibitor Tenofovir Leads to Preferential Distribution and Accumulation in Lymphatic Tissue. Antimicrobial Agents and Chemotherapy 49:5, pages 1898-1906.
Crossref
Crossref
Richard L. Mackman & Tomas Cihlar. 2004.
305
321
.
Erik De Clercq. (2003) Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections. Clinical Microbiology Reviews 16:4, pages 569-596.
Crossref
Crossref
Jiri Zemlicka. (2002) Lipophilic phosphoramidates as antiviral pronucleotides. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1587:2-3, pages 276-286.
Crossref
Crossref